BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11898528)

  • 1. T cells, cytokines, and autoantigens in multiple sclerosis.
    Gran B; Rostami A
    Curr Neurol Neurosci Rep; 2001 May; 1(3):263-70. PubMed ID: 11898528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathogenesis of the multiple sclerosis lesion.
    Markovic-Plese S; McFarland HF
    Curr Neurol Neurosci Rep; 2001 May; 1(3):257-62. PubMed ID: 11898527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
    Stinissen P; Raus J; Zhang J
    Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.
    Zang YC; Li S; Rivera VM; Hong J; Robinson RR; Breitbach WT; Killian J; Zhang JZ
    J Immunol; 2004 Apr; 172(8):5120-7. PubMed ID: 15067096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human autoreactive CD4+ T cells from naive CD45RA+ and memory CD45RO+ subsets differ with respect to epitope specificity and functional antigen avidity.
    Muraro PA; Pette M; Bielekova B; McFarland HF; Martin R
    J Immunol; 2000 May; 164(10):5474-81. PubMed ID: 10799915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors modifying the migration of lymphocytes across the blood-brain barrier.
    Brown KA
    Int Immunopharmacol; 2001 Nov; 1(12):2043-62. PubMed ID: 11710535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term evolution of autoreactive T cell repertoire in multiple sclerosis.
    Vergelli M; Mazzanti B; Traggiai E; Biagioli T; Ballerini C; Parigi A; Konse A; PellicanĂ² G; Massacesi L
    J Neurosci Res; 2001 Nov; 66(3):517-24. PubMed ID: 11746371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activation of ERK, p38, and JNK required for Th1 and Th2 deviation in myelin-reactive T cells induced by altered peptide ligand.
    Singh RA; Zhang JZ
    J Immunol; 2004 Dec; 173(12):7299-307. PubMed ID: 15585853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis: an altered immune response or an altered stress response?
    van Noort JM
    J Mol Med (Berl); 1996 Jun; 74(6):285-96. PubMed ID: 8862510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis.
    Hafler DA
    J Clin Invest; 1999 Sep; 104(5):527-9. PubMed ID: 10487765
    [No Abstract]   [Full Text] [Related]  

  • 12. Lessons from studies of antigen-specific T cell responses in Multiple Sclerosis.
    Martin R; Bielekova B; Gran B; McFarland HF
    J Neural Transm Suppl; 2000; (60):361-73. PubMed ID: 11205154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis: immune mechanism and update on current therapies.
    Bansil S; Cook SD; Rohowsky-Kochan C
    Ann Neurol; 1995 May; 37 Suppl 1():S87-101. PubMed ID: 8968220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive TCR responses to self antigens presented by different MHC class II molecules.
    Mycko MP; Waldner H; Anderson DE; Bourcier KD; Wucherpfennig KW; Kuchroo VK; Hafler DA
    J Immunol; 2004 Aug; 173(3):1689-98. PubMed ID: 15265898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis.
    Winer S; Astsaturov I; Cheung R; Gunaratnam L; Kubiak V; Cortez MA; Moscarello M; O'Connor PW; McKerlie C; Becker DJ; Dosch HM
    J Immunol; 2001 Feb; 166(4):2831-41. PubMed ID: 11160351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell autoimmunity in multiple sclerosis.
    Hohlfeld R; Londei M; Massacesi L; Salvetti M
    Immunol Today; 1995 Jun; 16(6):259-61. PubMed ID: 7544976
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
    Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).
    Hemmer B; Vergelli M; Calabresi P; Huang T; McFarland HF; Martin R
    J Neurosci Res; 1996 Sep; 45(6):852-62. PubMed ID: 8892097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation.
    Scholz C; Patton KT; Anderson DE; Freeman GJ; Hafler DA
    J Immunol; 1998 Feb; 160(3):1532-8. PubMed ID: 9570577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential molecular mimicry between the human endogenous retrovirus W family envelope proteins and myelin proteins in multiple sclerosis.
    Ramasamy R; Joseph B; Whittall T
    Immunol Lett; 2017 Mar; 183():79-85. PubMed ID: 28189601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.